Sigilon Therapeutics (SGTX) Stock Highlights

22.47 | +0%

2023-09-14 12:44:01

Sigilon Therapeutics Inc is a clinical stage biopharmaceutical company. The company is developing a new class of therapeutics and functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients. Its lead product candidate, SIG-001, prevents bleeding in patients with moderate-severe to severe Hemophilia A.

Statistics

Range Today

22.47 22.47

Volume Today 0

Range 1 Year

3.77 28

Volume 1 Year 9.9M

Range 3 Year

3.77 706.12

Volume 3 Year 14.79M

Range 10 Year

3.77 706.12

Volume 10 Year 14.79M

Highlights

Market Capitalization 56.22M (small)

Current Price 22.47

Performance

Latest 0%

1 Month +5.89%

3 Months +192.96%

6 Months +150.5%

1 Year +165.92%

3 Years -92.14%

5 Years -92.14%

10 Years -92.14%

Benchmarks

Market Capitalization

288 / 368

Gross Profits

176 / 278

Total Revenue

0 / 300

Total Rank

263 / 368

Free Cashflow

0 / 352

Performance 5 years

285 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.